Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parco Area Delle Scienze 17/A, 43124 Parma, Italy ...

A number of phage companies have emerged, but Locus is unique in its use of CRISPR-Cas3 to increase the effectiveness of phage therapy. It hopes to expand and improve the treatment options for ...

This organization has no public members. You must be a member to see who’s a part of this organization.

CRISPR-Cas systems are found in the genomes of ... strains CFBP2957 and K60T were challenged with a virulent phage, and the CRISPR arrays of bacteriophage-insensitive mutants (BIMs) were analysed.

Doudna, who spoke at The Granada Theatre in downtown Santa Barbara, invented Clustered Regularly Interspaced Short Palindromic (CRISPR)-Cas9 technology in 2012, which eventually earned her a Nobel ...

A patient with sickle cell disease died while participating in a clinical trial of a CRISPR-based treatment from Beam Therapeutics, threatening to overshadow early signals of effective gene editing.

ZUG, Switzerland and BOSTON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

Jennifer Doudna, the co-developer of CRISPR, says there’s a “coming revolution” in climate-adapted crops and animals. Jennifer Doudna, one of the inventors of the breakthrough gene-editing ...